S&P 500   2,992.36 (-0.19%)
DOW   26,856.93 (-0.63%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
GE   8.99 (-0.55%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
PRI   124.22 (+0.12%)
NFLX   276.16 (-5.86%)
GILD   64.23 (-1.53%)
DIS   131.27 (-0.83%)
S&P 500   2,992.36 (-0.19%)
DOW   26,856.93 (-0.63%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
GE   8.99 (-0.55%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
PRI   124.22 (+0.12%)
NFLX   276.16 (-5.86%)
GILD   64.23 (-1.53%)
DIS   131.27 (-0.83%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 EvotecHikma PharmaceuticalsAphriaHexoHEXO
SymbolETR:EVTLON:HIKTSE:APHATSE:HEXONASDAQ:HEXO
Price Information
Current Price€19.47GBX 1,993C$6.23C$3.65$2.77
52 Week RangeBuyHoldBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target€26.33GBX 1,848.57C$10.10C$8.98$7.45
% Upside from Price Target35.29% upside-7.25% downside62.12% upside145.89% upside169.54% upside
Trade Information
Market Cap$2.91 billion£4.82 billionC$1.60 billionC$925.74 million$722.12 million
BetaN/AN/AN/AN/AN/A
Average Volume1,360,000822,1383,649,7502,726,2703,637,759
Sales & Book Value
Annual Revenue$403.62 million£2.14 billionC$237.11 millionC$33.53 millionN/A
Price / Sales7.222.266.6126.45N/A
Cashflow€2.27 per shareGBX 139.89 per shareC$1.57 per shareC$0.73 per shareN/A
Price / Cash8.5714.253.965.00N/A
Book Value€2.93 per shareGBX 756.30 per shareC$6.79 per shareC$2.05 per shareN/A
Price / Book6.640.030.921.78N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPS€0.51GBX 148.80C($0.07)C($0.18)N/A
Trailing P/E Ratio38.3213.39N/AN/A0.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AC$0.59N/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AGBX 0.28C$0.76N/AN/A
Dividend YieldN/A0.01%12.20%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A0.19%N/A N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio99.79%37.69%28.19%7.80%N/A
Current Ratio3.24%1.28%5.64%5.62%N/A
Quick Ratio3.01%0.78%4.38%4.05%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees2,6178,400300374N/A
Shares Outstanding149.65 million242.30 million251.56 million242.98 million256.98 million
Next Earnings Date11/12/2019 (Estimated)N/AN/A10/24/2019 (Estimated)10/24/2019 (Confirmed)
OptionableNot OptionableNot OptionableOptionableOptionableOptionable
 EvotecHikma PharmaceuticalsAphriaHexoHEXO

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel